Current management of metastatic melanoma
- 15 December 2008
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 65 (24_Supplem) , S3-S9
- https://doi.org/10.2146/ajhp080460
Abstract
Purpose. Metastatic melanoma and current treatments are reviewed.Keywords
This publication has 25 references indexed in Scilit:
- Extracutaneous Malignant MelanomasCancer Investigation, 2008
- Chemotherapy Compared With Biochemotherapy for the Treatment of Metastatic Melanoma: A Meta-Analysis of 18 Trials Involving 2,621 PatientsJournal of Clinical Oncology, 2007
- Management of Metastatic MelanomaSeminars in Oncology, 2007
- Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous MelanomaJournal of Clinical Oncology, 2007
- Complex Combination Biochemotherapy Regimen in Advanced Metastatic Melanoma in a Non-intensive Care Unit: Toxicity or Benefit?Japanese Journal of Clinical Oncology, 2007
- Selective Lymphopenia and Opportunistic Infections in Neuroendocrine Tumor Patients Receiving TemozolomideCancer Investigation, 2007
- Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study GroupJournal of Clinical Oncology, 2006
- Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid TumorsClinical Cancer Research, 2006
- Inhibition of angiogenesis by non-toxic doses of temozolomideAnti-Cancer Drugs, 2003
- The incidence of malignant melanoma in the United States: Issues as we approach the 21st centuryJournal of the American Academy of Dermatology, 1996